The role of IL-17 and anti-IL-17 agents in the immunopathogenesis and management of autoimmune and inflammatory diseases
S.P. Déo-Gracias Berry(Centre de Recherche Médicales de Lambaréné), Zeineb Zian(Abdelmalek Essaâdi University), Haleh Hamedifar(Biotechnology Research Center), Araz Sabzvari(Biotechnology Research Center), Gholamreza Azizi(Jefferson Hospital for Neuroscience), Niusha Sharifinejad(Universal Scientific Education and Research Network), Ali Kashif(Abdul Wali Khan University Mardan), Camille Dossou(Université d'Abomey-Calavi)
Cited by 123
Related Papers
Interleukin-6 cytokine: An overview of the immune regulation, immune dysregulation, and therapeutic approach
|International Immunopharmacology|2022|384
Interleukin-18 cytokine in immunity, inflammation, and autoimmunity: Biological role in induction, regulation, and treatment
|Frontiers in Immunology|2022|363
Coronavirus disease 2019 (COVID‐19): An overview of the immunopathology, serological diagnosis and management
|Scandinavian Journal of Immunology|2020|339
The significant role of interleukin-6 and its signaling pathway in the immunopathogenesis and treatment of breast cancer
|Biomedicine & Pharmacotherapy|2018|312
Primary immunodeficiency and autoimmunity: A comprehensive review
|Journal of Autoimmunity|2019|239